Literature DB >> 24271188

Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity.

Eric Sterner1, Lingyun Li, Priscilla Paul, Julie M Beaudet, Jian Liu, Robert J Linhardt, Jonathan S Dordick.   

Abstract

O-sulfotransferases (OSTs) are critical enzymes in the cellular biosynthesis of the biologically and pharmacologically important heparan sulfate and heparin. Recently, these enzymes have been cloned and expressed in bacteria for application in the chemoenzymatic synthesis of glycosaminoglycan-based drugs. OST activity assays have largely relied on the use of radioisotopic methods using [(35)S] 3'-phosphoadenosine-5'-phosphosulfate and scintillation counting. Herein, we examine alternative assays that are more compatible with a biomanufacturing environment. A high throughput microtiter-based approach is reported that relies on a coupled bienzymic colorimetric assay for heparan sulfate and heparin OSTs acting on polysaccharide substrates using arylsulfotransferase-IV and p-nitrophenylsulfate as a sacrificial sulfogroup donor. A second liquid chromatography-mass spectrometric assay, for heparan sulfate and heparin OSTs acting on structurally defined oligosaccharide substrates, is also reported that provides additional information on the number and positions of the transferred sulfo groups within the product. Together, these assays allow quantitative and mechanistic information to be obtained on OSTs that act on heparan sulfate and heparin precursors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24271188      PMCID: PMC3901155          DOI: 10.1007/s00216-013-7470-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  42 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

4.  Kinetic analysis of NodST sulfotransferase using an electrospray ionization mass spectrometry assay.

Authors:  Na Pi; Joshua I Armstrong; Carolyn R Bertozzi; Julie A Leary
Journal:  Biochemistry       Date:  2002-11-05       Impact factor: 3.162

5.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

Authors:  R E Jordan; G M Oosta; W T Gardner; R D Rosenberg
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.

Authors:  Tasneem Islam; Melissa Butler; Sulthan A Sikkander; Toshihiko Toida; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2002-11-19       Impact factor: 2.104

7.  Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides.

Authors:  M D Burkart; M Izumi; E Chapman; C H Lin; C H Wong
Journal:  J Org Chem       Date:  2000-09-08       Impact factor: 4.354

8.  Adenosine-5'-phosphosulfate kinase from Escherichia coli K12. Purification, characterization, and identification of a phosphorylated enzyme intermediate.

Authors:  C Satishchandran; G D Markham
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

Review 9.  Heparin-protein interactions.

Authors:  Ishan Capila; Robert J Linhardt
Journal:  Angew Chem Int Ed Engl       Date:  2002-02-01       Impact factor: 15.336

10.  Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1.

Authors:  Suzanne C Edavettal; Karen A Lee; Masahiko Negishi; Robert J Linhardt; Jian Liu; Lars C Pedersen
Journal:  J Biol Chem       Date:  2004-04-01       Impact factor: 5.157

View more
  9 in total

1.  Combinatorial one-pot chemoenzymatic synthesis of heparin.

Authors:  Ujjwal Bhaskar; Guoyun Li; Li Fu; Akihiro Onishi; Mathew Suflita; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2014-11-07       Impact factor: 9.381

2.  High cell density cultivation of recombinant Escherichia coli strains expressing 2-O-sulfotransferase and C5-epimerase for the production of bioengineered heparin.

Authors:  Jianhua Zhang; Matt Suflita; Guoyun Li; Weihong Zhong; Lingyun Li; Jonathan S Dordick; Robert J Linhardt; Fuming Zhang
Journal:  Appl Biochem Biotechnol       Date:  2015-01-14       Impact factor: 2.926

Review 3.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

4.  Elucidating the unusual reaction kinetics of D-glucuronyl C5-epimerase.

Authors:  Deepika Vaidyanathan; Elena Paskaleva; Troy Vargason; Xia Ke; Scott A McCallum; Robert J Linhardt; Jonathan S Dordick
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

5.  Heavy Heparin: A Stable Isotope-Enriched, Chemoenzymatically-Synthesized, Poly-Component Drug.

Authors:  Brady F Cress; Ujjwal Bhaskar; Deepika Vaidyanathan; Asher Williams; Chao Cai; Xinyue Liu; Li Fu; Vandhana M-Chari; Fuming Zhang; Shaker A Mousa; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Angew Chem Int Ed Engl       Date:  2019-04-01       Impact factor: 15.336

Review 6.  Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.

Authors:  Matthew Suflita; Li Fu; Wenqin He; Mattheos Koffas; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-29       Impact factor: 4.813

Review 7.  Bioengineered heparins and heparan sulfates.

Authors:  Li Fu; Matthew Suflita; Robert J Linhardt
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

8.  Complete biosynthesis of a sulfated chondroitin in Escherichia coli.

Authors:  Abinaya Badri; Asher Williams; Adeola Awofiranye; Payel Datta; Ke Xia; Wenqin He; Keith Fraser; Jonathan S Dordick; Robert J Linhardt; Mattheos A G Koffas
Journal:  Nat Commun       Date:  2021-03-02       Impact factor: 14.919

Review 9.  Engineered heparins as new anticoagulant drugs.

Authors:  Deepika Vaidyanathan; Asher Williams; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Bioeng Transl Med       Date:  2016-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.